Product Information
BPR1K871 is a synthetic, orally bioavailable anticancer compound that has potent anticancer activity. It is a multi-kinase inhibitor that inhibits the activity of aurora kinases A and B, AKT, ERK1/2, and JNK. BPR1K871 also inhibits the enzymatic activity of PDGFRβ kinase, which is involved in the proliferation of cancer cells. BPR1K871 has been shown to have no significant impurities and is stable in human plasma. This compound has been shown to have potent anticancer activity in preclinical studies with no toxicity to normal cells.
Chemical properties
Technical inquiry about: 3D-TXD76735 BPR1K871
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
